This week in Other Barks & Bites: The International Trade Commission issues a limited exclusion order and cease and desist order for patent-infringing technology in the Apple Watch; Taco Bell wins its last battle against Taco Tuesday trademark; and President Biden announces the recipients of the National Medal of Science and the National Medal of Technology and Innovation.
This week in Washington IP news, a House subcommittee holds a hearing on advances in deepfake technology. Elsewhere, the Peterson Institute hosts the launch of an OECD report that looks at how governments can spur growth in the green economy, and the USPTO holds a three-day event for newcomers to the patent application process.
This week in Other Barks & Bites: the Court of Justice of the European Union rules that criminal sentencing for trademark infringement cannot be disproportionate to the offense committed; the Federal Circuit affirms several Patent Trial and Appeal Board (PTAB) decisions invalidating VirnetX patent claims underlying a nine-figure jury verdict in U.S. district court; PhRMA tells the White House that…
This week in Other Barks & Bites: U.K. politicians warn of widespread copyright infringement on NFT marketplaces; Google announces it will assume legal responsibility to offer customers protection from copyright disputes caused by the tech firm’s generative AI; Caltech and Apple jointly file a request to dismiss the patent infringement lawsuit between the two.
This week in Other Barks & Bites: The U.S. Supreme Court denies a hearing to music publishers who accused a website of infringing on the copyright of live music performances; the U.S. Court of Appeals for the Federal Circuit (CAFC) issues two precedential patent opinions; X Social Media sues Elon Musk’s social media platform X for copyright infringement; and the PTAB grants Mylan Pharmaceutical’s petition for an inter partes review on the validity of Novo Nordisk’s Ozempic and Wegovy patents.
This week in Washington IP news, Congress starts a two-week district work period, but there are still several interesting events taking place in the nation’s capital. The U.S. Patent and Trademark Office (USPTO) is holding an event on anticounterfeiting and anti-piracy strategies, as well as a discussion on how to enforce IP rights in Mexico. Elsewhere, New America is digging into the federal government’s efforts to spur domestic development in emerging technology.
This week in Other Barks & Bites: the Supreme Court grants a copyright case; the Writers Guild of America reaches an agreement with Hollywood studios that offers writers some copyright protections from AI-generated scripts; the CAFC affirms a PTAB decision that invalidated a medical alarm patent; and Getty Images releases a commercially safe AI generative tool.
This week in Washington IP news, the U.S. Patent and Trademark Office (USPTO) discusses how innovators and the Office can use AI tools to their advantage. The Hudson Institute turns its attention to U.S. trade policy, including important trends in semiconductor geopolitics. Elsewhere, the House Science Committee will look into how the EPA uses technology and research development to support local partners and other stakeholders.
This week in Other Barks & Bites: CAFC says reasonable expectation of success findings can be implicit when combined with other analyses; Yale University settles a ketamine patent royalty dispute with the Department of Veterans Affairs for $1.5 million; the USPTO announces Mary Fuller as the new director of the Silicon Valley Regional Office; a group of famous authors files a lawsuit against OpenAI accusing the generative AI company of copyright infringement.
This week in Other Barks & Bites: the CAFC issues a precedential ruling in a design patent win for Columbia Sportswear; the country’s biggest tech CEOs testify before Congress on the state of artificial intelligence (AI) in the United States; the Federal Trade Commission releases a policy statement charging that brand pharmaceutical companies are improperly listing patents in the Orange Book; and the IFPMA explained the pharmaceutical industry’s priorities of innovation and pandemic preparedness.
This week in Other Barks & Bites: A California district court dismisses a copyright infringement lawsuit against musicians Sam Smith and Nomani; the U.S. Copyright Office denies an award-winning artist copyright registration on an AI-generated piece of art; and a Delaware district judge reveres a jury ruling that awarded $15.1 million to a company that accused Google of patent infringement.
This week in Other Barks & Bites: The Federal Circuit affirms a win for Sierra Wireless at the Patent Trial and Appeal Board in a precedential ruling on Friday; Google launches a program to watermark AI-generated images; the CAFC affirms a PTAB ruling that invalidated a patent that claimed technology related to Meta’s News Feed; and an economic consultancy firm releases a report that argues rule changes to the IPR system could cost the U.S. economy nearly half-a-billion dollars.
This week in Other Barks & Bites: The U.S. Patent and Trademark Office (USPTO) announced Friday it is extending the deadline on its Request for Comments on anticounterfeiting and antipiracy strategies by one month, to September 25, 2023; tobacco company Altria files a complaint against e-cigarette maker Juul alleging patent infringement of e-cigarette technology; a Trader Joe’s workers’ union files a motion to dismiss a trademark infringement lawsuit filed by the supermarket chain; and the New York Knicks accuse the Toronto Raptors of an NBA trade secrets heist.
This week in Other Barks & Bites: Senator Ted Cruz introduces draft legislation to clarify federal law on college athletes’ name, image, likeness (NIL) rights; American Axle gets win on remanded claim in district court; inventors lament “As Seen on TV” infringement; AstraZeneca pays Bristol Myers Squibb to settle patent infringement lawsuit.
This week in Other Barks & Bites: Two U.S. senators propose a bill to protect U.S. businesses from foreign IP theft; a jury orders Google to pay a developer $338 million in damages for patent infringement; and UN officials question the impact of the EU’s proposed trade agreements with countries that produce generic medications.